Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
Clinical trial NCT03937479 · COMPLETED
Trial details
- NCT number
- NCT03937479
- Sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2019-11-15
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.